Logo
x

Search category

Subscribe Now

Rani Therapeutics

Rani Therapeutics Initiates P-I Study of RT-111 (biosimilar, ustekinumab) for Autoimmune Diseases

Rani Therapeutics Initiates P-I Study of RT-111 (biosimilar, ustekinumab) for Autoimmune Diseases

  • September 19, 2023
Rani Therapeutics Expands its Collaboration with Celltrion to Develop Oral Version of Humira Biosimilar RT-105

Rani Therapeutics Expands its Collaboration with Celltrion to Develop Oral Version of Humira Biosimilar RT-105

  • June 6, 2023
Rani Therapeutics Highlighted RT-111 Development Program for Multiple Indications

Rani Therapeutics Highlighted RT-111 Development Program for Multiple Indications

  • October 24, 2022
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.